FilingReader Intelligence
China Resources Sanjiu proposes dividend and equity increase
March 12, 2025 at 05:17 PM UTC•By FilingReader AI
China Resources Sanjiu Medical & Pharmaceutical (CR Sanjiu) [SZSE:000999] has announced its proposed 2024 equity distribution plan, highlighting a commitment to shareholder returns alongside business growth. The plan includes a cash dividend of RMB 3.2 per 10 shares (before tax) and a bonus share distribution of 3 new shares for every 10 shares held. This is in addition to an interim dividend paid out of the year’s profits.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
2024 Annual Audit ReportMarch 12, 2025 at 11:31 AM UTC
Annual special audit report on related party funds misappropriationMarch 12, 2025 at 11:31 AM UTC
2024 Annual ReportMarch 12, 2025 at 11:31 AM UTC
2024 Annual Report SummaryMarch 12, 2025 at 11:31 AM UTC
Summary of non-operating capital occupation and other related capital transactions of listed companies in 2024March 12, 2025 at 11:31 AM UTC
Announcement on the Provision for Impairment of Various Assets in 2024March 12, 2025 at 11:31 AM UTC
Internal Control Audit ReportMarch 12, 2025 at 11:31 AM UTC
SZSE:000999•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when China Resources Sanjiu Medical & Pharmaceutical publishes news
Free account required • Unsubscribe anytime